These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35476257)

  • 21. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.
    Vandeva S; Yaneva M; Natchev E; Elenkova A; Kalinov K; Zacharieva S
    Endocrine; 2015 Aug; 49(3):774-82. PubMed ID: 25561370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency.
    Elbornsson M; Horvath A; Götherström G; Bengtsson BÅ; Johannsson G; Svensson J
    Eur J Endocrinol; 2017 Feb; 176(2):99-109. PubMed ID: 27803031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.
    Roerink SH; Wagenmakers MA; Wessels JF; Sterenborg RB; Smit JW; Hermus AR; Netea-Maier RT
    Pituitary; 2015 Jun; 18(3):366-75. PubMed ID: 24965695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
    Chin SO; Chung CH; Chung YS; Kim BJ; Kim HY; Kim IJ; Kim JG; Kim MS; Kim SY; Lee EJ; Lee KY; Kim SW
    BMJ Open; 2015 Jun; 5(6):e006898. PubMed ID: 26063564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
    T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
    Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort.
    Moock J; Friedrich N; Völzke H; Spielhagen C; Nauck M; Koltowska-Häggström M; Buchfelder M; Wallaschofski H; Kohlmann T
    Growth Horm IGF Res; 2011 Oct; 21(5):272-8. PubMed ID: 21865066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study.
    Sardella C; Lombardi M; Rossi G; Cosci C; Brogioni S; Scattina I; Webb SM; Gasperi M; Martino E; Bogazzi F
    J Endocrinol Invest; 2010 Jan; 33(1):20-5. PubMed ID: 20203538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly.
    Postma MR; Netea-Maier RT; van den Berg G; Homan J; Sluiter WJ; Wagenmakers MA; van den Bergh AC; Wolffenbuttel BH; Hermus AR; van Beek AP
    Eur J Endocrinol; 2012 Apr; 166(4):585-92. PubMed ID: 22250074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).
    Suzukamo Y; Noguchi H; Takahashi N; Shimatsu A; Chihara K; Green J; Fukuhara S
    Growth Horm IGF Res; 2006; 16(5-6):340-7. PubMed ID: 17081792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly.
    Jawiarczyk-Przybyłowska A; Szcześniak D; Ciułkowicz M; Bolanowski M; Rymaszewska J
    Front Endocrinol (Lausanne); 2019; 10():899. PubMed ID: 32010060
    [No Abstract]   [Full Text] [Related]  

  • 32. Total score or subscales in scoring the acromegaly quality of life questionnaire: using novel confirmatory methods to compare scoring options.
    Felt JM; Depaoli SA; Pereira AM; Biermasz NR; Tiemensma J
    Eur J Endocrinol; 2015 Jul; 173(1):37-42. PubMed ID: 25872514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hypopituitarism and quality of life in survivors of post-traumatic brain injury.
    Bensalah M; Donaldson M; Labassen M; Cherfi L; Nebbal M; Haffaf EM; Abdennebi B; Guenane K; Kemali Z; Ould Kablia S
    Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00146. PubMed ID: 32704567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis.
    Wirén L; Whalley D; McKenna S; Wilhelmsen L
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):143-52. PubMed ID: 10671940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysis.
    Kołtowska-Häggström M; Kind P; Monson JP; Jonsson B
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):122-9. PubMed ID: 17803700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.
    Wassenaar MJ; Biermasz NR; Kloppenburg M; van der Klaauw AA; Tiemensma J; Smit JW; Pereira AM; Roelfsema F; Kroon HM; Romijn JA
    Growth Horm IGF Res; 2010 Jun; 20(3):226-33. PubMed ID: 20194043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and quality of life responses to octreotide-LAR in acromegaly.
    Mangupli R; Camperos P; Webb SM
    Pituitary; 2014 Dec; 17(6):495-9. PubMed ID: 24178448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using EQ-5D to derive general population-based utilities for the quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA).
    Kołtowska-Häggström M; Jonsson B; Isacson D; Bingefors K
    Value Health; 2007; 10(1):73-81. PubMed ID: 17261118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.
    Kołtowska-Haggstrom M; Hennessy S; Mattsson AF; Monson JP; Kind P
    Horm Res; 2005; 64(1):46-54. PubMed ID: 16103683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.